V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20163864 | 20063079 | 1.58 | 69.2 | Neo-adjuvant (N) | 2017-01-24 | 2017-01-30 | ECX | 2 | N | ECX | 100556854 |
| 20163869 | 20063080 | 0 | 83.5 | Neo-adjuvant (N) | 2017-10-18 | 2017-10-21 | ECX | 02 | N | ECX | 101343285 |
| 20163872 | 20063081 | 1.6 | 52.3 | Adjuvant (A) | 2016-10-11 | 2016-10-29 | ECX | 02 | N | ECX | 100705895 |
| 20163880 | 20063082 | 1.6 | 78.2 | Palliative (P) | 2016-09-21 | 2016-10-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100081997 |
| 20163882 | 20063083 | 1.62 | 52 | Adjuvant (A) | 2020-01-01 | 2020-01-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101510593 |
| 20163884 | 20063084 | null | null | Palliative (P) | 2016-07-23 | 2016-08-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100567649 |
| 20163887 | 20063085 | 1.64 | 65.7 | Neo-adjuvant (N) | 2019-05-23 | 2019-05-23 | ECX | N | N | ECX | 100486353 |
| 20163898 | 20063086 | 1.52 | 72.3 | Neo-adjuvant (N) | null | 2016-11-21 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100792068 |
| 20163902 | 20063087 | 1.73 | 100.9 | Neo-adjuvant (N) | 2016-09-15 | 2016-09-22 | ECX | 02 | N | ECX | 100303651 |
| 20163904 | 20063088 | null | null | Neo-adjuvant (N) | 2016-05-20 | 2016-05-30 | ECX | 02 | null | ECX | 100193379 |
| 20163912 | 20063089 | 1.8 | 68.1 | Adjuvant (A) | 2019-09-20 | 2019-10-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101049802 |
| 20163914 | 20063090 | 1.61 | 78.5 | Palliative (P) | 2018-09-26 | 2018-10-18 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100225134 |
| 20163916 | 20063091 | 1.51 | 74 | Palliative (P) | 2016-12-14 | 2017-01-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101865015 |
| 20163917 | 20063092 | 1.82 | 82.9 | Palliative (P) | 2017-09-06 | 2017-10-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101063992 |
| 20163931 | 20063093 | 1.72 | 64.7 | Neo-adjuvant (N) | 2018-09-19 | 2018-09-23 | Gemcitabine + Capecitabine | null | N | ECX | 100819746 |
| 20163937 | 20063094 | 1.72 | 67.2 | Palliative (P) | 2016-12-05 | 2016-12-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100234425 |
| 20163939 | 20063095 | 1.8 | 79.8 | Palliative (P) | 2017-02-26 | 2017-04-21 | ECX | N | N | ECX | 100032148 |
| 20163947 | 20063096 | null | 70 | Palliative (P) | null | null | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101009109 |
| 20163949 | 20063097 | 1.71 | 101 | Neo-adjuvant (N) | 2017-02-14 | 2017-02-23 | ECX | N | N | ECX | 101109741 |
| 20163952 | 20063098 | 1.76 | 67.4 | null | null | 2019-09-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101811434 |
| 20163958 | 20063099 | 1.56 | 51.7 | Adjuvant (A) | 2018-01-22 | 2018-01-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100759634 |
| 20163959 | 20063100 | 1.72 | 61.2 | Neo-adjuvant (N) | 2018-06-15 | 2018-06-15 | ECX | N | N | ECX | 101812749 |
| 20163962 | 20063101 | 1.61 | 60 | Neo-adjuvant (N) | 2016-01-27 | 2016-02-03 | ECX | 02 | N | ECX | 101343583 |
| 20163966 | 20063102 | 1.83 | 73.2 | Adjuvant (A) | 2017-10-26 | 2017-10-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101559762 |
| 20163967 | 20063103 | 1.89 | 76.6 | Adjuvant (A) | 2019-03-17 | 2019-03-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101242372 |
| 20163971 | 20063104 | 1.56 | 122 | Palliative (P) | 2016-12-04 | 2016-12-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100289975 |
| 20163975 | 20063105 | 1.88 | 55 | Palliative (P) | 2017-01-16 | 2017-01-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100945761 |
| 20163985 | 20063106 | 1.66 | 92.6 | Neo-adjuvant (N) | 2016-06-28 | 2016-07-12 | ECX | null | N | ECX | 101836892 |
| 20163996 | 20063107 | 1.66 | 90.9 | Palliative (P) | 2017-03-20 | 2017-03-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100497521 |
| 20164001 | 20063108 | 1.78 | 102 | null | 2018-05-31 | 2018-06-20 | ECX | N | N | ECX | 101217396 |
| 20164006 | 20063109 | 1.53 | 90 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-09 | ECX | N | N | ECX | 101175012 |
| 20164014 | 20063110 | 1.75 | 88.6 | Adjuvant (A) | 2017-05-05 | 2017-05-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100995613 |
| 20164016 | 20063111 | 1.65 | 86.1 | Neo-adjuvant (N) | 2017-07-18 | 2017-07-22 | ECX | 02 | null | ECX | 100003570 |
| 20164027 | 20063112 | 1.72 | 52.55 | Neo-adjuvant (N) | 2018-06-25 | 2018-07-01 | ECX | 2 | null | ECX | 100052670 |
| 20164030 | 20063113 | 1.65 | 75 | null | 2018-07-16 | 2018-07-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101414357 |
| 20164031 | 20063114 | 1.55 | 63.2 | Palliative (P) | 2017-03-21 | 2017-03-21 | ECX | 2 | N | ECX | 101355201 |
| 20164032 | 20063115 | 180.3 | 62.3 | Palliative (P) | 2018-11-11 | 2018-12-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101566553 |
| 20164033 | 20063116 | 1.61 | 68.2 | Palliative (P) | 2019-03-28 | 2019-03-28 | ECX | 2 | N | ECX | 101679366 |
| 20164038 | 20063117 | 1.72 | 77 | Adjuvant (A) | 2018-10-21 | 2018-10-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100339493 |
| 20164039 | 20063118 | 1.79 | 83.6 | null | 2017-09-14 | 2017-09-22 | ECX | N | N | ECX | 100055348 |
| 20164046 | 20063119 | 1.64 | 65.6 | null | 2017-02-18 | 2017-03-05 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101731465 |
| 20164057 | 20063120 | 1.54 | 86.5 | Palliative (P) | 2019-03-28 | 2019-04-18 | ECX | N | N | ECX | 100587579 |
| 20164058 | 20063121 | 1.58 | 76.5 | Palliative (P) | 2017-11-04 | 2017-11-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100385131 |
| 20164059 | 20063122 | 1.7 | 83.6 | null | 2018-01-20 | 2018-01-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100326810 |
| 20164064 | 20063123 | 1.6 | 71.6 | Palliative (P) | 2017-06-24 | 2017-06-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101625970 |
| 20164068 | 20063124 | 1.54 | 67.9 | Neo-adjuvant (N) | 2019-06-03 | 2019-06-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101827155 |
| 20164071 | 20063125 | 1.56 | 61 | Curative (C) | 2018-01-12 | 2018-01-26 | ECX | 02 | null | ECX | 100165712 |
| 20164073 | 20063126 | 1.7 | 50.8 | Neo-adjuvant (N) | 2016-04-25 | 2016-05-05 | ECX | null | N | ECX | 100910500 |
| 20164075 | 20063127 | 1.55 | 53.3 | Neo-adjuvant (N) | 2016-08-26 | 2016-08-27 | ECX | 02 | N | ECX | 100004469 |
| 20164078 | 20063128 | 1.82 | 101.8 | Adjuvant (A) | 2019-04-09 | 2019-07-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101758235 |